Pacira BioSciences

Yahoo Finance • 2 hours ago

Pharmacorp Rx Inc. Reports Q3 2025 Financial Results

SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a growing national platform for pharmacist-led community pharmacy ownership, today reported its financial resu... Full story

Yahoo Finance • 2 hours ago

PharmaCorp Announces Executive Transition and New Director of Business Development

SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) today announced an executive transition in which Paul Dale has been appointed President and Chief Operating Of... Full story

Yahoo Finance • 2 days ago

Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical

-- Lawsuit triggers 30-month stay under the Hatch Waxman Act -- BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain th... Full story

Yahoo Finance • 16 days ago

PharmaCorp Announces Supplemental Listing of Warrants

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan, Nov. 13, 2025 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to... Full story

Yahoo Finance • 16 days ago

PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Nov. 12, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. – PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX)... Full story

Yahoo Finance • 23 days ago

PharmaCorp Announces Upsized C$20 Million Bought Deal Public Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan, Nov. 06, 2025 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to... Full story

Yahoo Finance • 23 days ago

PharmaCorp Announces C$15 Million Bought Deal Public Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan, Nov. 05, 2025 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to... Full story

Yahoo Finance • 30 days ago

Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025

BRISBANE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that... Full story

Yahoo Finance • last month

Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®

BRISBANE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients today reported it has... Full story

Yahoo Finance • last month

Pacira down after FDA filing for generic Exparel

[painkillers, dependence on pills. The concept] Pavel Kot/iStock via Getty Images Shares of Pacira BioSciences (NASDAQ:PCRX [https://seekingalpha.com/symbol/PCRX]) fell on Tuesday after the company announced that a subsidiary of a Chinese... Full story

Yahoo Finance • last month

Pacira BioSciences to Present 3-Year Data Demonstrating Sustained Pain and Function Improvements in Knee Osteoarthritis with Investigational PCRX-201 Gene Therapy

-- Poster to be presented at American College of Rheumatology Convergence 2025 – BRISBANE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative,... Full story

Yahoo Finance • last month

PharmaCorp Rx Inc. Files Final Short Form Base Shelf Prospectus

SASKATOON, Saskatchewan, Oct. 17, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV:PCRX) is pleased to announce that it has filed its Final Short Form Base Shelf Prospectus dated October 14, 2025 (the... Full story

Yahoo Finance • 2 months ago

PharmaCorp Refiles Q2 2025 Financial Statements

SASKATOON, Saskatchewan, Oct. 10, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has restated and refiled its financial statements for the interim period ended June 30, 2025 (the “Amended Q2... Full story

Yahoo Finance • 2 months ago

Pacira BioSciences Becomes Oversold (PCRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 2 months ago

PharmaCorp Closes Acquisitions of Three Pharmacies Across Canada

SASKATOON, Saskatchewan, Oct. 02, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has completed the acquisitions of three community pharmacy businesses, two loca... Full story

Yahoo Finance • 2 months ago

PharmaCorp Rx Inc. Files Preliminary Short Form Base Shelf Prospectus

SASKATOON, Saskatchewan, Sept. 29, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV:PCRX) is pleased to announce that it has filed a preliminary short form base shelf prospectus with the securities co... Full story

Yahoo Finance • 3 months ago

PharmaCorp to Acquire a Pharmacy in Ontario for $5,300,000, New Non-Binding Letter of Intent to Acquire Two Pharmacies in Eastern Canada, Updates on Previously Announced Non-Binding Letters of Intent and Filing of Q2 Investor Presentation

SASKATOON, Saskatchewan, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the signing of a definitive share purchase agreement to acquire a 100% interest in a P... Full story

Yahoo Finance • 3 months ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting o... Full story

Yahoo Finance • 3 months ago

PharmaCorp to Acquire Two Pharmacies in Western Canada

SASKATOON, Saskatchewan, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into definitive share purchase agreements, each dated August 29, 2... Full story

Yahoo Finance • 3 months ago

PharmaCorp Rx Inc. Reports Q2 2025 Financial Results

SASKATOON, Saskatchewan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a growing national platform for pharmacist-led community pharmacy ownership, today reported its financial resu... Full story